Arterial Stiffness clinical trials

Explore recruiting arterial stiffness clinical trials.

Recruiting arterial stiffness studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Arterial Stiffness trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of vascular stiffness in patients with autosomal dominant polycystic kidney disease

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Double-blind, placebo-controlled clinical trial to determine the effect of Patiromer on vascular function and its relationship with mineral metabolism parameters

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

The COlchicine HypERtENsion Trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized crossover clinical trial regarding the blockage of the mineralocorticoid receptor using Eplerenone on the evolution of arterial stiffness in kidney patients one year after transplant: EVATRAN (The effect of Eplerenone on the evolution of Vasculopathy in renal transplant patients).

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

REPLACE - A multi-centre, randomised, double-blinded, placebo controlled 16-weeks study to compare the effect of hydrocortisone and placebo in patients with Giant Cell Arteritis (GCA)/ Polymyalgia Rheumatica (PMR) with patient-reported symptoms of adrenal insufficiency after cessation of glucocorticoid treatment.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION - ENDOTHELIN-2

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Arterial Stiffness trials by city

Arterial Stiffness in Toronto Arterial Stiffness in Vancouver Arterial Stiffness in Montreal Arterial Stiffness in Calgary Arterial Stiffness in Edmonton Arterial Stiffness in Ottawa Arterial Stiffness in Winnipeg Arterial Stiffness in Quebec City Arterial Stiffness in Hamilton Arterial Stiffness in Kitchener Arterial Stiffness in London Arterial Stiffness in Halifax Arterial Stiffness in New York Arterial Stiffness in Los Angeles Arterial Stiffness in Chicago Arterial Stiffness in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease